Vitreous haemorrhage is a serious complication of proliferative diabet
ic retinopathy : it provides evidence of the severity of at proliferat
ive retinopathy at stake and precludes laser photocoagulation. In some
cases of moderate vitreous haemorrhage, panretinal photocoagulation r
emains possible especially using longer wavelengths such as krypton re
d; cryotherapy under ophthalmoscopic control may be an alternative to
panretinal photocoagulation. Developpement of pars plana vitrectomy, h
owever, has been the main break the rough in the management of severe
vitreous haemorrhage. Pars plana vitrectomy was first reserved to mass
ive, long-standing vitreous haemorrhage; improvements in instrumentati
on and techniques, as well as observations of the favourable effect of
vitrectomy on the progression of proliferative retinopathy led to enl
arger indications for pars plana vitrectomy. Beyond severity and durat
ion of visual loss, main arguments for pars plana vitrectomy are bilat
erality, lack of previous panretinal photocoagulation, iris neovascula
rization, Type 1 diabetes, and severity of fibrovascular proliferation
.